Flow Neuroscience

Flow Neuroscience has developed a clinically validated at-home brain stimulation headset using transcranial Direct Current Stimulation (tDCS) combined with a behavioral therapy app for the treatment of depression. The device has received medical certification in the EU and UK, FDA Breakthrough Device Designation in the US, and demonstrated safety and efficacy across multiple large independent clinical trials. Over 25,000 users have been treated to date with <5% experiencing side effects. Real-world data from NHS pilots show significant reductions in depression symptoms including up to a 75% drop in self-harm/suicidal feelings among some patients.